Scarica l'app Stockscreener
81.79
0.57%
0.46
Dopo l'orario di chiusura:
81.79
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché INSP Giù?
Forum
Previsione
Precedente Chiudi:
$81.33
Aprire:
$79.2
Volume 24 ore:
982.04K
Relative Volume:
0.62
Capitalizzazione di mercato:
$2.38B
Reddito:
$861.31M
Utile/perdita netta:
$53.12M
Rapporto P/E:
47.38
EPS:
1.7262
Flusso di cassa netto:
$85.01M
1 W Prestazione:
-13.40%
1M Prestazione:
-14.33%
6M Prestazione:
-36.53%
1 anno Prestazione:
-55.63%
Intervallo 1D:
$78.45
$81.93
Intervallo di 1 settimana:
$77.75
$97.52
Portata 52W:
$70.77
$203.12
Inspire Medical Systems Inc Stock (INSP) Company Profile
Nome
Inspire Medical Systems Inc
Settore
Industria
Telefono
763-957-5037
Indirizzo
5500 WAYZATA BLVD, GOLDEN VALLEY
Confronta INSP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
81.79 | 2.36B | 861.31M | 53.12M | 85.01M | 1.7262 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2026-01-22 | Downgrade | Truist | Buy → Hold |
| 2025-12-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Aggiornamento | Truist | Hold → Buy |
| 2025-11-25 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Aggiornamento | Stifel | Hold → Buy |
| 2025-11-04 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Downgrade | Jefferies | Buy → Hold |
| 2025-09-22 | Downgrade | UBS | Buy → Neutral |
| 2025-09-02 | Iniziato | Evercore ISI | Outperform |
| 2025-08-05 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Downgrade | Truist | Buy → Hold |
| 2024-11-20 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-05-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-04-19 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-03-19 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Iniziato | Jefferies | Buy |
| 2024-01-02 | Downgrade | Stifel | Buy → Hold |
| 2023-12-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-04-14 | Iniziato | Mizuho | Buy |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-12-13 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-12-15 | Downgrade | Goldman | Buy → Neutral |
| 2020-11-03 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-11-03 | Aggiornamento | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Iniziato | JP Morgan | Overweight |
| 2020-09-02 | Iniziato | Robert W. Baird | Outperform |
| 2020-08-06 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-07-15 | Iniziato | Goldman | Buy |
| 2020-06-18 | Reiterato | Piper Sandler | Overweight |
| 2020-05-18 | Iniziato | Lake Street | Buy |
| 2020-04-28 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Iniziato | Piper Sandler | Overweight |
| 2020-01-28 | Iniziato | Oppenheimer | Underperform |
| 2020-01-27 | Iniziato | Oppenheimer | Underperform |
| 2019-11-06 | Aggiornamento | Berenberg | Sell → Hold |
| 2019-02-05 | Iniziato | Dougherty & Company | Buy |
| 2018-11-28 | Iniziato | Berenberg | Sell |
| 2018-10-29 | Iniziato | Leerink Partners | Outperform |
| 2018-05-29 | Iniziato | Guggenheim | Buy |
| 2018-05-29 | Iniziato | Stifel | Buy |
| 2018-05-29 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Inspire Medical Systems Inc Borsa (INSP) Ultime notizie
Forecasting The Future: 19 Analyst Projections For Inspire Medical Systems - Benzinga
Equities Analysts Issue Forecasts for INSP FY2027 Earnings - MarketBeat
A Look At Inspire Medical Systems (INSP) Valuation After CMS Reimbursement Uncertainty - simplywall.st
Y Intercept Hong Kong Ltd Grows Stock Holdings in Inspire Medical Systems, Inc. $INSP - MarketBeat
Baillie Gifford & Co. Sells 29,538 Shares of Inspire Medical Systems, Inc. $INSP - MarketBeat
Assessing Inspire Medical Systems (INSP) Valuation After A Difficult Year For Shareholder Returns - Yahoo Finance
Wells Fargo is bullish on Inspire Medical Systems, Inc. (INSP) despite short-term reimbursement concerns - MSN
Inspire Medical Systems, Inc. (NYSE:INSP) Given Average Rating of "Hold" by Brokerages - MarketBeat
Analyst Upgrade: Will ZKH Group Limited Depositary Receipt benefit from geopolitical trendsWeekly Gains Report & Community Consensus Picks - baoquankhu1.vn
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Maintains Target Price $96 - 富途资讯
(INSP) Volatility Zones as Tactical Triggers - Stock Traders Daily
Inspire downgraded at Oppenheimer following CMS NCD correction - MSN
Inspire Medical Systems (NYSE:INSP) Shares Down 7.5% After Analyst Downgrade - MarketBeat
Inspire Medical Systems Board Under Investigation, 2025 Earnings Guidance Cut by Over 80% - Intellectia AI
The Law Offices of Frank R. Cruz Announces Investigation of Inspire Medical Systems, Inc. (INSP) on Behalf of Investors - marketscreener.com
Truist Securities downgrades Inspire Medical stock on coding setback By Investing.com - Investing.com Canada
Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why - Finviz
Inspire Medical Systems (NYSE:INSP) Cut to "Hold" at Truist Financial - MarketBeat
CMS removes OSA coverage for Inspire Medical Systems reimbursement uplift - Investing.com Canada
Inspire Medical (INSP) Faces Downgrade Amid Coding Changes - GuruFocus
Inspire Medical stock tumbles after CMS removes sleep apnea coverage By Investing.com - Investing.com Canada
Here's Why You Should Retain INSP Stock in Your Portfolio for Now - Finviz
Oppenheimer downgrades Inspire Medical stock on CMS reimbursement reversal By Investing.com - Investing.com Canada
INSP Shares Drop Following CMS Correction and Analyst Downgrade - GuruFocus
Inspire Medical (INSP) Faces Medicare Reimbursement Adjustment - GuruFocus
Inspire Medical Systems (NYSE:INSP) Lowered to "Market Perform" Rating by Oppenheimer - MarketBeat
Wells Fargo Is Bullish on Inspire Medical Systems, Inc. (INSP) Despite Short-Term Reimbursement Concerns - Finviz
Aug Macro: What are Inspire Medical Systems Incs growth levers2025 Earnings Surprises & Daily Entry Point Alerts - baoquankhu1.vn
2 Reasons to Watch INSP and 1 to Stay Cautious - Finviz
Update Report: Can Inspire Medical Systems Inc sustain earnings growthJuly 2025 Highlights & AI Powered Market Entry Strategies - baoquankhu1.vn
Inspire Medical Systems, Inc. (INSP): Stock Analysis Highlights 50% Potential Upside for Investors - directorstalkinterviews.com
A Look At Inspire Medical Systems (INSP) Valuation After New Growth Guidance And CFO Appointment - Sahm
Inspire Medical Systems, Inc. (INSP): A Bull Case Theory - Finviz
Swing Trade: What is JYNTs P E ratio telling usWeekly Stock Recap & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Wells Fargo Maintains Overweight Rating on INSP, Lowers Price Ta - GuruFocus
Will New CFO Hire And Inspire V Launch Plus 2026 Guidance Change Inspire Medical Systems' (INSP) Narrative? - Yahoo Finance
Insider Sell: John Rondoni Sells Shares of Inspire Medical Syste - GuruFocus
JPM26: Inspire Medical Systems projects a strong 2026 - Yahoo Finance
Inspire appoints Matt Osberg as CFO - MedTech Dive
Impulse Dynamics® Announces New Chief Financial Officer - The Manila Times
Inspire Medical Systems appoints Matt Osberg as new CFO By Investing.com - Investing.com Nigeria
Inspire Medical Systems (NYSE:INSP) Insider Sells $10,900.00 in Stock - MarketBeat
Inspire Medical Systems Issues Strong Preliminary 2025 Revenue Results - TipRanks
Jefferies raises Inspire Medical Systems stock price target to $100 on strong Q4 - Investing.com Canada
Inspire Medical Systems (NYSE: INSP) sets CFO transition, preliminary 2025 results - Stock Titan
INSP: Inspire V drives growth with improved outcomes, strong guidance, and ongoing innovation - TradingView — Track All Markets
INSP: Inspire 5's launch accelerates growth, innovation, and patient outcomes, with strong 2026 outlook - TradingView — Track All Markets
Inspire Medical names new CFO, reports preliminary Q4 results - MassDevice
Inspire Medical Systems announces Q4 and FY25 guidance, appoints new CFO - MSN
INSP Forecasts 10%-11% Growth by 2025 - GuruFocus
Inspire Medical Systems (INSP) Reports Strong Revenue Growth in 2025 - GuruFocus
Inspire Medical Systems Inc Azioni (INSP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.36%
0.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):